Legacy Financial Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Buy
11,942
+5,691
+91% +$309K 0.06% 243
2026
Q1
$392K Buy
6,251
+1,295
+26% +$104K 0.05% 273
2025
Q4
$473K Sell
4,956
-759
-13% -$74.4K 0.07% 231
2025
Q3
$558K Sell
5,715
-1,079
-16% -$112K 0.08% 213
2025
Q2
$730K Buy
6,794
+1,218
+22% +$123K 0.11% 158
2025
Q1
$563K Buy
5,576
+256
+5% +$25.8K 0.09% 176
2024
Q4
$475K Buy
5,320
+1,343
+34% +$118K 0.08% 199
2024
Q3
$333K Sell
3,977
-130
-3% -$10.2K 0.06% 257
2024
Q2
$316K Buy
4,107
+247
+6% +$18.1K 0.06% 242
2024
Q1
$264K Sell
3,860
-13
-0.3% -$836 0.05% 266
2023
Q4
$224K Buy
+3,873
New +$207K 0.04% 275
2019
Q2
Sell
-464
Closed -$18K 228
2019
Q1
$18K Buy
464
+413
+810% +$15.8K 0.01% 471
2018
Q4
$2K Sell
51
-103
-67% -$3.74K ﹤0.01% 833
2018
Q3
$5K Hold
154
﹤0.01% 676
2018
Q2
$5K Buy
+154
New +$4.64K ﹤0.01% 686
2018
Q1
Sell
-108
Closed -$2K 823
2017
Q4
$2K Buy
+108
New +$2.98K ﹤0.01% 729

Other funds holding BSX

Legacy Financial Advisors's BSX Position: Q2 2026 in Review

Legacy Financial Advisors increased its Boston Scientific (BSX) stake by 91% in Q2 2026, buying an estimated $309K and bringing the position to 11,942 shares worth $510K. The position accounts for 0.06% of the portfolio, ranked #243.

Legacy Financial Advisors first reported a position in BSX in Q4 2017 and has held it in 16 quarters since. The position peaked at $730K in Q2 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Legacy Financial Advisors held 11,942 shares of Boston Scientific worth $510K as of Q2 2026.
  • Legacy Financial Advisors bought 5,691 Boston Scientific shares in Q2 2026, an estimated $309K.
  • Boston Scientific made up 0.06% of Legacy Financial Advisors's portfolio in Q2 2026, its #243 holding.
  • Legacy Financial Advisors first reported a position in Boston Scientific in Q4 2017 and has held it in 16 quarters since.
  • Legacy Financial Advisors's Boston Scientific position peaked at $730K in Q2 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Legacy Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.